Unitedhealth Group Inc

UnitedHealth Group posted a better-than-expected third quarter, delivering earnings per share of $2.92 against a consensus estimate of $2.81, a beat of 3.98%, even as the insurer grappled with severe margin pressure that defined the quarter's broader narrative. Revenue climbed 12.2% year-over-year to $113.16 billion, edging past the $113.06 billion consensus, but the headline growth masked a painful earnings squeeze; operating income was cut roughly in half as the medical care ratio surged 470 basis points to 89.9%, driven by elevated utilization trends, Medicare funding reductions, and the structural disruption of the Inflation Reduction Act's Part D overhaul. UnitedHealthcare's Medicare and Retirement segment was the top-line standout, with revenues reaching $43.36 billion on 24% growth fueled by 625,000 net new Medicare Advantage members, though profitability across both the insurance and Optum Health units deteriorated sharply. Despite the cost headwinds that have contributed to significant year-to-date pressure on the stock, management raised its full-year 2025 adjusted EPS outlook to at least $16.25, signaling confidence in a sequential recovery and positioning for accelerating growth into 2026.